Ming Zhou

4PUBLICATIONS
20CO-AUTHORS
Gene and molecular therapyHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 31, 2023
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results.

Adi Diab, Helen Gogas, Shahneen Sandhu

|Jul 30, 2020
Bempegaldesleukin plus nivolumab in untreated, unresectable or metastatic melanoma: Phase III PIVOT IO 001 study design.

Nikhil I Khushalani, Adi Diab, Paolo A Ascierto

|Apr 18, 2018
Predictive probability methods for interim monitoring in clinical trials with longitudinal outcomes.

Ming Zhou, Qi Tang, Lixin Lang

Pageof 1